03/04/2025
π Last week, the FDA removed Semaglutide from its βshortageβ list.
π Compounded medications can only be prescribed while that medication remains on the FDA βshortageβ list.
π Without current litigation, compounded Semaglutide must cease distributions by May 22nd, 2025.
π If you are currently prescribed Semaglutide, I would encourage you to refill your prescription prior to this date.
π If you have more questions, please schedule a visit through the link below to discuss further.
π: https://practice.kareo.com/virtualwellnesssolutions
https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize